Authors: Masamitsu Okada, Satoshi Yamashita, Hidetsugu Ueyama, Masatoshi Ishizaki, Yasushi Maeda, and Yukio Andob
Article title: Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis
Title of scholarly journal and date published: May 17, 2018
The newsmakers are docotors who are writing about the new drug Edaravone, its a free radical scavenger that was approved as a therapeutic drug for ALS in 2015 in Japan. A clinical trial demonstrated a smaller decline in ALS. However, the long-term effects of edaravone on ALS patients remain unclear. The article investigate the long-term effects of edaravone on the survival of ALS patients. Because the drug is fairly new, the long term effects have not been discovered yet. However when taking the drug there are the usual side effects such as headache, skin inflammation or rash, eczema, respiratory failure, respiratory disorder, and oxygen deficiency. The drug also either works or it doesn’t.
acacia - wonders of a nurse blog 